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A b s t r a c t  
Alginate nanocapsules of ethanolic extract of Enicostemma littorale (NEL) were prepared by 
emulsification, cross linking with calcium chloride and solvent removal. Based on total phenol 
content the loading efficiency of the nanocapsules was 89% at an optimum concentration of 2: 18 
(mg ml -1) for plant extract: olive oil. The photon correlation spectroscopy (PCS) revealed that the 
mean particle diameter of optimized formulation was 233 nm and scanning electron microscopy 
(SEM) showed a spherical morphology. When subjected to Fourier transform infrared spectroscopy 
(FT-IR) for the compatability analysis between plant extract and sodium alginate, it revealed that the 
phytoconstituents were stable. The purpose of the present study was to compare the anti-diabetic 
activity of NEL and E.littorale (EL) in streptozoticin induced male rats. An oral dose of NEL (20 
mg/kg b.w) and EL (2000 mg/kg b.w) showed a relatively similar antidiabetic effect, reducing the 
blood glucose, triglycerides, cholesterol, creatinine, ALT, AST, and ALP. Moreover, NEL is 100 times 
less than EL exhibiting better results within 10 days of treatment. These biochemical assessments 
were supported by rat biopsy examinations. In conclusion, the nanoemulsification method can be 
applied for poor water-soluble ethanolic herbal extracts to reduce the dosage and time. 
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Introduction 
Diabetes mellitus, a chronic metabolic disorder affecting 
approximately 4% of the population worldwide, is expected to be 
increased to 5.4% in 2025 [1] and is estimated to afflict 5-7% of 
the population [2]. The insulin metabolism and impaired function 
in carbohydrate, lipid and protein metabolism lead to long-term 
complications related to deficiency in the insulin action or 
secretion. Major complications such as retinopathy [3] 
nephropathy [4] and neuropathy [5,6] lead to long-term damage, 
dysfunction, and failure of various organs, such as the eyes, 
kidneys, nerves, heart and blood vessels, creating a huge 
economic burden related to the management of diabetic 
complications [7]. Enicostemma littorale (Gentianaceae) is a 
small perennial herb used for the treatment of Diabetes mellitus. 
It contains six phenolic compounds, flavonoids and aminoacids, 
five alkaloids, two sterols and volatile oil [8]. Previous studies 
have demonstrated the antidiabetic activity of aqueous extract of 
E. littorale in type-2 diabetic rats [9] and alloxan induced diabetic 
rats [10-13]. The biochemical constituents of the plant are 
important sources of natural antioxidants and the efficacy of the 
plant extract is more when they are consumed as a crude extract 
[14]. However, the major limitation is that the quantity of herbal 
extract required for treatment is higher due to the degradation of 
various plant constituents such as alkaloids, amides, 
prophenylphenols, steroids, hydrocinnamic acid and oxalic acid 
in the gastro intestinal tract and a longer duration of treatment is 
needed due to the poor absorption of these constituents in the 
intestine [15]. 
Recently, many studies focused on encapsulation of the plant 
extracts to enhance the sustained release of the constituents, in 
the intestine, for maximum absorption [16-19]. Apart from other 
nanoencapsulation methods, nanoemulsification is more 
advantageous since the targeted drug is usually packed in an 
inner phase which is released in a sustainable manner for a 
longer period and kept away from direct contact with body and 
tissue fluids [20] due to two immiscible liquids oil-in-water (O/W), 
water-in-oil (W/O), oil-in-water-oil (O/W/O) and water-in-oil-water 
(W/O/W) being dispersed as small spherical droplets in the other 
[21]. Their size ranges from 0.1-100 mm [22]. 
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In the present study, nanoemulsification of Enicostemma littorale 
by emulsioncoacervation method was prepared and 
characterized by using scanning electron microscopy (SEM), 
photon correlation spectroscopy (PCS) and Fourier transform 
infrared spectroscopy (FTIR). Our aim was to evaluate repeated 
dose toxicity and to compare the antidiabetic effect of 
nanoemulsified ethanolic extracts of E. littorale (NEL) and E. 
littorale (EL) in streptozoticin induced diabetic male rats. 
Materials and methods 
Extraction and preparation of nanoemulsified 
ethanolic extracts using sodium 
alginate 
The leaves of E. littorale were collected, washed thoroughly with 
several changes of sterile water followed by 70% ethanol, blotted 
between fields of filter paper (Whatman No.1), shade dried and 
homogenized. The homogenate was extracted in 99% ethanol 
for 8 h in Soxhlet distillation and the solvent was evaporated at 
room temperature (28-30ºC). 
The residue was lyophilized (Christ lyophilizer, German) and 
stored in -20ºC until further use. The authenticity of the plant 
species were verified by Botanical survey of India, (Coimbatore, 
India). 
Nanoencapsulation was performed using a three step procedure 
- emulsification, crosslinking with calcium chloride and solvent 
removal [23, 24]. Dispersion of ethanolic plant extract in aqueous 
sodium alginate (molecular weight of 80,000-120,000 Da, Sigma 
Chemicals, St Louis, MO, USA containing Tween 80®) solution 
caused immediate formation of micelles with an oil core. The 
alginate emulsion was cross-linked with analytical grade calcium 
chloride and solvent was removed by evaporation under 
pressure. Nanocapsules containing plant extract were obtained 
as dispersion in aqueous phase. 
Variation in proportion of plant extract and olive oil 
The optimal plant extract: olive oil mass ratio for 
nanoemulsification was determined using varied proportions 
(0.005:0.195, 0.01:0.190, 0.02:0.180, 0.03:0.17,0.06:0.14 and 
0.15:0.05) dissolved in 10 ml of ethanol to obtain a final 
concentration of 2% and mixed with 10 ml of aqueous alginate 
(0.6 mg ml-1) (1:1 ratio) at pH 7.0 containing 1% (w/v) Tween 
80®. After sonication for 15 min, the emulsion was combined 
with 4 ml of 0.67 mg ml-1 CaCl2 solution and continuously stirred 
for 30 min. The plant extract-loaded alginate nanocapsule 
suspension was then equilibrated overnight prior to removal of 
ethanol by rotary evaporation at 40 °C for 20 min. Finally, the 
alginate nanocapsules containing plant extract were obtained as 
dispersion in aqueous solution. Based on the turbidity, the 
maximum emulsion formed was visually monitored. Then the 
emulsion was washed with sterile water and filtered in a 0.45 μm 
size filter. The total phenolic content was calculated for ethanolic 
plant extract extract, sodium alginate emulsion without plant 
extract and the emulsion formed at varying concentrations, 
before and after filtration by using Folin–Ciocalteu reagent 
method [25] using gallic acid as a standard. This method was 
employed to evaluate the phenolic content of the samples. 100 
μl of the sample was dissolved in 500 μl (1/10 dilution) of Folin–
Ciocalteu reagent and 1000 μl of distilled water. The solutions 
were mixed and incubated at room temperature for 1 min. After 1 
min, 1500 μl of 20% sodium carbonate (Na2CO3) solution was 
added. The final mixture was shaken and then incubated for 2 h 
in the dark at room temperature. The absorbance of all samples 
was measured at 760 nm using Orbit Technology UV–Vis 
spectrophotometer. The results were expressed in mg of gallic 
acid (GEA) per mg of plant extract  
Total phenol content before filtration 
Loading Efficiency (%) = x 100 
Total phenolic content after filtration 
Determination of particle size 
Particle size was determined using photon correlation 
spectroscopy (PCS) (MalvernS4700PCSSystem, Malvern,UK). 
For particle size analysis, the nanoemulsified plant extract was 
first suspended in 100ml of filtered water (0.2 μm filter, Ministart, 
Germany) and then subjected to sonication for 30s and vortex 
mixing for 10s before analysis. 
Characterization of nanocapsules 
The shape and surface morphology of nanoemulsions were 
examined using scanning electron microscopy (SEM) (JSM-T20, 
Tokyo, Japan). An appropriate sample of polymeric 
nanoparticles was mounted on metal stubs, using double-sided 
adhesive tapes. 
The samples were gold coated and observed for morphology, at 
an acceleration voltage of 15 kV. 
Chemical stability of the nanoemulsified ethanolic 
extracts 
Lyophilized samples mixed with potassium bromide at a ratio of 
1:100 (w/w) were laminated using a pellet mold in Fourier 
transform infrared (FT-IR). Spectra of ethanolic extract, 
encapsulated extract and extract released from alginate beads 
were obtained using FT-IR spectrometer (Shimadzu, Japan) by 
scanning between 4000–400cm−1. 
Storage Stability of the nanoemulsified ethanolic 
extracts 
The physical stability of the plant extract loaded nanocapsules 
was determined by the assessment of average size after storage 
at 4ºC and 28ºC for two months. The encapsulation efficiency 
was determined at weekly interval based on the turbidity. The 
Deepa V et al. International Journal of Phytomedicine 4 (1) 70-89 [2012] 
 
PAGE | 72 | 
 
 
 
release profile was microscopically observed. Based on the total 
phenol content the loading efficiency was calculated for the 
release of phytoconstituents at 28 and 4ºC for the 
nanoemulsified ethanolic herbal extracts. 
In vitro release of nanoemulsified extracts at acidic 
pH (1.2) and alkaline pH (7.2). 
To study the release kinetics, the nanocapsules were treated 
separately with two solutions an acidic (simulated gastric fluid, 
pH 1.2) and simulated intestinal fluid pH 7.2 (phosphate buffered 
saline, pH 7.5) at 37°C. The release profile of the 
phytoconstituents at different hours from the nanoemulsion was 
calculated based on total phenol content (TPC) (before and after 
filtration) and converting into the loading efficiency as mentioned 
above. 
Test animals and treatment pattern 
Male albino rats of Wistar strain (Rattus norvegicans) weighing 
100-120 g were used for the study. The animals were housed in 
a group of 3 rats per cage under wellcontrolled conditions of 
temperature (21±2 º C), humidity (50-60%) in 12h/12h light-dark 
cycle. Animals had free access to diet (Tetragon Chemie Pvt. 
Ltd., Bangalore, India) and water ad libitum. Diabetics was 
induced with STZ (sigma Ltd, USA) 50 mg/kg) administered as a 
single intraperitoneal injection to overnight fasted animals. 
Animals were checked for the glucose levels after 5 days of STZ 
injection. Animals showing glucose (>250 mg/dL) were 
considered as diabetic and they were divided in to 5 groups each 
group containing 6 animals. The study protocol was approved by 
the Institutional Animal Ethics Committee. 
Group 1: (negative Control) sterile water was orally dosed during 
entire duration of the study 
Group 2: (diabetic control) Diabetic induced with STZ were orally 
dosed with sterile water during the entire duration of the study 
Group 3: (Plant extract, 2000 mg/kg body weight) Diabetic 
induced with STZ was administered orally with plant 
extract(obtained by ethonolic extraction using Soxhlet, ethanol 
was evaporated by lyophilisation and stored) mixed with corn oil, 
which has already been proved in literature for anti-diabetic 
activity 
Group 4: Diabetic induced with STZ was treated orally by 
administering with unnanotised plant extract (20 mg/Kg body 
weight) 
Group 5: Diabetic induced with STZ was treated orally by 
administering with nanoemulsified plant extract (20 mg/kg body 
weight) 
Group 6: (Reference drug, Insulin) 1 U/kg through intraperitoneal 
route of administration 
Group 7: Plant extract 2000 mg/kg body weight was 
administered orally for 20 days. 
Group 8: Nanoemulsified plant extract of 20 mg/kg body weight 
was administered orally for 20 days. 
Clinical signs and body weight 
All the animals in the study were observed twice daily for overt 
signs of toxicity, morbidity and mortality during the entire study 
period. At the beginning of the treatment, and at every 3rd day, 
thereafter, body weight was measured, i.e., on the 4th, 7th, 10th, 
13th, 16th, 19th, 22nd and 25th day after treatment. 
Blood sample collection and analysis 
Blood was collected on the 5th, 10th, 15th, 20th and 25th day after 
treatment from orbital sinus of all the animals. Heparinized 
plasma used for biochemical analysis was obtained by 
centrifugation at 1500 x g for 20 min. The following clinical 
biochemistry parameters glucose, total cholesterol, triglycerides, 
creatinine, aspartate transaminase (AST), alanine transaminase 
(ALT) and alkaline phosphatase (ALP) were analyzed by using 
fully automated biochemistry analyzer (Humastar 300, Human 
GmbH, Germany). For all determinations, Human (Human 
GmbH., Germany) reagent kits were used. 
Gross Necropsy 
All the animals were sacrificed at the end of the treatment period 
(Day 25) using CO2 and were subjected to a full, detailed gross 
necropsy which included careful examination of the external 
surface of the body, all orifices, the cranial, thoracic and 
abdominal cavities and their contents. 
Histopathology 
A piece of the pancreas, liver and kidney of all the test animal 
were fixed with 10% neutral buffered formalin, embedded in 
paraffin wax, sectioned at a thickness of approximately 3-5 
microns and stained with hematoxylin-eosin. A detailed 
histopathological examination was performed on the tissues 
(Pancreas, liver and kidney) from all the animals of the G1-G8 
groups. The following grading system was used for 
histopathologic evaluation in the study: 1 – Minimal, 2 – Mild, 3 – 
Moderate, 4 –Marked, 5 – Severe 
Statistical analysis 
The data is expressed as mean ± standard deviation. For 
statistical analysis, the experimental values were compared with 
the non-diabetic control. Data were analyzed by Modified 
Leven’s test for homogeneity and subjected to one-way analysis 
of variance (ANOVA). A comparison of treated with non-diabetic 
control groups were done using Newman-Keuls Multiple-
Comparison Test. If data was found to be heterogeneity, it was 
subjected to non-parametric test (Kruskal – Wallis Multiple-
Comparison Z-Value Test). The alpha level at which all tests 
were conducted is 0.05 and NCSS 2007 software was used for 
analysis. 
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Results 
Nanotisation of plant extracts using sodium alginate with 
variation in parameters The total phenol content of the original 
plant extract was 0.18±0.02 mg GEA/ mg of ethanolic extract of 
E. littorale. Based on the total phenol content (before and after 
filtration) for NEL the loading efficiency was calculated , Different 
concentrations were tried to calculate the encapsulation 
efficiency, in some concentrations the encapsulation efficiency 
was less due to aggregation which will not form the 
nanocapsules. This can be only by monitoring the phenol content 
before and after filtration. At lower concentration of the extract 
there was no difference in the total phenol content before and 
after filtration. However at higher concentrations of the extract 
the phenol content is more in the filtrate showing the possible 
less of phenols indicating the reduction in the encapsulation 
efficiency. 
This suggested that the optimum ratio of 2% of [plant extract (2 
mg ml-1): olive oil (18 mg ml-1)] dissolved in ethanol and mixed 
with sodium alginate (0.6 mg ml-1) at a ratio of 1:1 and cross 
linked with 0.2 ml of calcium chloride for 1ml of total mixture 
(0.67 mg ml-1), the loading efficiency was 89% for NEL at pH 7.0 
(Figure 1A, B). The optimum encapsulation efficiency was 
attained at 0.02:0.180 mg/10 ml of ethanol. This was significantly 
different from other concentrations tested. The polydispersity 
index value less than 0.3 is of narrow distribution and more than 
0.3 is of broad distribution. The mean particle diameter is 
213±4.4 nm, which indicated that the NEL showed an excellent 
narrow distribution (Figure 2A) and microscopically, the 
nanocapsules were spherical in shape (Figure 2B, C). The FT-IR 
spectrum of sodium alginate nanocapsules crosslinked with 
CaCl2, plant extract of E. littorale without nanoencapsulation and 
with nanoencapsulation where shown in (Figure 3A, B, C).The 
fingerprint characteristic vibrations bands of sodium alginate 
nanocapsules appear at 3320 (OH- stretching vibrations) 2924 
(C-H stretching), 2852 (C-H stretching), 2362 (C-H stretching), 
1747 (C=O streching), 1103 (ester C-O group) and 952 
(aromatic CH bending).FT-IR of E. littorale showed peaks at 
3439 (OH- stretching vibrations), 2920 (C-H stretching), 2850 (C-
H stretching), 2366 (C-H stretching), 1747 (C=O streching), The 
bands at 1568, 1432, 1381 and 1329 are due to C-O streching 
and 899 (aromatic CH bending).The common peaks that appear 
both in sodium alginate nanocapsules and plant extract E. 
littorale were 3439. 2922, 2852, 2357, 1342, 1037 and the 
common peaks that appear between plant extract E. littorale and 
the nanoemulsified E. littorale were 1384, 1452, 1643 , 1643. 
From the FT-IR profile it is confirmed that all functional groups of 
E. littorale were present after interaction with the polymer. The 
FT-IR determined for the chemical stability of the original plant 
extract, nanocapsules with plant extract and for sodium alginate 
nanocapsules without plant extract showed that the 
characteristic bands of chemical groups remain unchanged for E. 
littorale. 
 
Storage stability of nanoemulsion 
The effect of storage temperature (4ºC and 28ºC) on the total 
phenol content of nanocapsules containing ethanolic plant 
extract [(plant extract/olive oil ratio of 0.02:0.190 mg ml-1); 
alginate ratio =1:1] was evaluated. The total phenol content and 
loading efficiency analysis revealed that the nanocapsules were 
fairly stable when stored for 60 days at 4ºC. The loading 
efficiency was significantly similar (p>0.05) until 8 weeks of 
storage for E. littorale (Figure 4A, B), which was different on 8th 
week of storage at 4 ºC (p<0.05). However, nanocapsules stored 
at 28 ºC released the total phenol content within a period of 3 
weeks (Figure 4C, D) for E. littorale. 
In-vitro release of nanoemulsion at alkaline and acidic 
pH 
When studied in in-vitro conditions of using simulated gastric 
fluid (pH 1.2), the total phenols (Figure 5A) were released slowly 
till 4 h of incubation, and maximum release was observed after 4 
h of incubation. Based on the total phenol content (GEA mg/ml of 
extract) the loading efficiency was calculated for different periods 
of incubation at acidic pH (1.2) and the total phenol content from 
the nanoemulsion was not released until 3 h of incubation at 
pH(1.2). Statistical difference did not exist in the loading 
efficiency until 3rd h of incubation and from 4th - 8th h which is 
statistically different from 1st h *-(p<0.05, ANOVA) (Figure 5B) for 
E. littorale. At alkaline pH (7.2), 98% of nanocapsules total 
phenol content were released within 4 h of incubation (Figure 
5C) for E. littorale. Based on the total phenol content (GEAmg/ml 
of extract) the loading efficiency was calculated for different 
periods of incubation at acidic pH (1.2) and the total phenol 
content from the nanoemulsion was not released until 4th hour of 
incubation at pH (7.2). Statistical difference did not exist in the 
loading efficiency until 3rd h of incubation and from 4th - 8th h 
which is statistically different from 1st h *-(p<0.05, ANOVA) 
(Figure 5D) for E. littorale. In this study with the presence of 
sodium alginate, at acidic and alkaline pH, the emulsion was 
formed and loading efficiency was comparatively good but the 
polyphenol content was very less because it was sensitive to pH. 
Morbidity/mortality and Clinical signs 
No morbidity/mortality was observed in the animals from G1 
(negative Control), G2 (diabetic Control), G3 (streptozoticin 
induced diabetics treated with plant extract, 2000 mg/kg), G4 
(streptozoticin induced diabetics treated with unnanotised plant 
extract, 20 mg/kg), G5 (streptozoticin induced diabetics treated 
nanoemulsified plant extract) , G6 (Reference drug -insulin), G7 
(treated only with plant extract, 2000mg/kg for 20 days), and G8 
( treated only with nanotized plant extract , 20mg/kg for 20 days) 
None of the animals in G1, G7, and G8 showed any clinical signs 
of toxicity throughout the observation period. However, diabetes 
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induced animals in G2 and G4 showed clinical signs like 
polyuria, polydypsia, change of body coat color and piloerrection 
throughout the observation period whereas the above clinical 
signs remained in G3 until the 15th day, and in G5 and G6 until 
the 7th day. (Table 1A, B). 
Body weight 
All the animals in G1, G3, G5, G6, G7 and G8 showed constant 
body weight gain throughout the observation period (Table 2). 
However, mean body weight of animals in G2 and G4 showed 
significant decrease when compared to mean body weight of 
animals in G1. There was no significant difference in mean body 
weights of animals in G3, G5 and G6 when compared with mean 
body weight of animals in G1. This suggests that there was no 
constant body weight gain in diabetic induced animals in G3, G4, 
G5 and G6 when compared with bodyweight gain of non-diabetic 
animals (G1) throughout the observation period. 
Plasma profile 
Significant changes were observed in biochemistry parameters 
such as fasting glucose, triglycerides and ALP in animals 
belonging to G2, G3, G4, G5 and G6 on Day 5, Day 10, Day 15, 
Day 20 and Day 25 compared to non-diabetic control (G1). The 
group G5 showed a decrease in the plasma fasting glucose, 
triglycerides and ALP on 10th day when compared with other 
treated groups G3, G4 and G6. The creatinine, AST and ALT 
showed no significant difference to non-diabetic control (Figure 
6A, B, C, D, E, F). 
Urinalysis 
Urinalysis performed on day 25, showed no abnormal findings in 
G1, G3, G5, G6, G7 and G8. However, significant increase in 
glucose and ketone as well as decrease in specific gravity was 
observed in G2 and G4 when compared to G1 (Table 3). 
Histopathology for the STZ induced diabetics in rat 
Pancreas 
Based on stained tissue sections, there were no notable 
changes in pancreas histology in normal rats (Figure 7A, B) In 
contrast, STZ administration showed shrunken pancreas, 
number of islets was reduced profoundly, along with vacuolar 
degeneration of islet cells and fibrosis focally (Figure 8A, B, C). 
Administration of EL (2000 mg/kg b.w) (Figure 9A, B), showed 
restoration of damaged islets and significantly reduced injuries to 
the pancreas by restricting further damage. Administration of EL 
(20 mg/kg b.w) (Figure 10A, B), showed no improvement in the 
histopathological changes when compared with the treatment 
groups of EL (2000 mg/kg b.w), NEL and insulin. Administration 
of NEL (20 mg/kg bw) (Figure 11 A, B) and Insulin (Figure 12A, 
B) showed a better protective effect in the numbers, size and 
shape of islets and in vacuolar degeneration,. The rats treated 
only with EL (2000 mg/kg b.w) and with NEL (20 mg/kg b.w) 
showed normal histology like control rats, 2-3 islets in a view, 
normal round Shape and size (Figure 13). 
Histopathology for the STZ induced diabetics in rats 
of kidney 
Based on stained tissue sections, there were no notable 
changes in kidney histology showing normal cortex and pelvis 
(Figure 14 A, B) normal tubules and glomerulus (Figure 15 A, B) 
in normal rats. In contrast, STZ administration resulted in severe 
injury to the kidney causing mesangial proliferation in 
glomerulus, reduced bowman’s space and glomerular 
hemorrhage resulting in glomerulopathy. Additionally the diabetic 
rats exhibited tubular dilation in cortex and dilated pelvis (Figure 
16A, B) and (Figure 17). Administration of EL (2000 mg/kg b.w) 
(Figure 18) showed moderate protective effect. Administration of 
EL (20 mg/kg b.w) (Figure 19A, B), showed no improvement in 
the histopathological changes when compared with the treatment 
groups of EL (2000 mg/kg b.w), NEL and insulin. Administration 
of NEL (20 mg/kg bw) (Figure 20 A, B) and Insulin (Figure 21A, 
B) showed a better protective effect for tubular dilatation, 
bowman’s space, mesangial proliferation reduced remarkably 
thus reducing the severity of glomerulopathy. 
Histopathology of the kidney treated with EL (2000 mg/kg b.w) 
and NEL (20 mg/kg b.w) showed normal histological 
appearances like control rats indicating no toxicity to the rat 
kidney due to the E,littorale (2000 mg/kg b.w) and NEL. 
Discussion 
To date, there have been no investigations on nanoemulsified 
ethanolic extracts of E.littorale (NEL) for antidiabetic activity. In 
the present study, ethanolic extract which contains almost all 
phytoconstituents and which has poor water solubility, was 
confined in nanocapsules by emulsion coacervation method. 
Then the efficacy of NEL was compared with EL for the 
antidiabetic activity in STZ induced diabetic male rats. When the 
STZ was injected to adult rats, loss of body weight, polydypsia, 
change of body coat color and piloerrection, characteristics of 
diabetes mellitus were caused, which is similar to the report [26]. 
The loss of body weight could be due to dehydration and 
catabolism of fats and proteins [27, 28]. Type I diabetes is 
characterized by an absolute deficiency of insulin secretion, 
associated with auto-immune destruction of pancreatic beta-
cells. The increased activities of ALT, AST and ALP in the serum 
of diabetic rats may be primarily due to the leakage of these 
enzymes from liver cytosol into the blood stream as a 
consequence of the hepatotoxic effect of STZ [29-32]. 
Surprisingly, we found that the required dose of NEL was 100 
times lower (20 mg/kg b.w.) than that of EL (2000 mg/kg b.w.) to 
decrease the glucose levels and other biochemistry parameters 
within a period of 10 days and significantly increase the body 
weight of the STZ treated animals. Based on stained tissue 
sections, there were no notable changes in the pancreas 
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histology of normal rats. In contrast, STZ administration resulted 
in severe injury to the pancreas, such as decreasing of the islets 
cells’ number, vacuolation, fibrosis, degeneration diminishing of 
the diameter of the pancreatic gland. Administration of NEL (20 
mg/kg bw), EL (2000 mg/kg b.w) and Insulin showed low  
expansion of islets and significantly reduced the injuries to the 
pancreas. These results were supported by diabetes arising from 
destruction of the beta islet cells of the pancreas, causing 
degranulation or reduction of insulin secretion [33]. The 
mechanism of glucose transport and insulin secretion is that 
glucose transporters carry the glucose into the beta cells which 
are then metabolized in glycolysis /Krebs cycle and produce 
large amount of ATP/ADP in the cytoplasm, which leads to 
closing of (KATP channels) due to ATPsensitive potassium 
channels. Consequently, the cell membrane is polarized which 
activates the Ca2+ channel. As a result, there is more influx of 
Ca2+ into the cytoplasm which stimulates insulin secretion. 
Incase of EL the mechanism of insulin secretion as reported by 
[11], is due to beta cell damage by STZ (streptozoticin), the 
insulin secretion is stopped, thus, the glucose is not metabolized 
by glycolysis/krebs cycle. Therefore there is an increase in the 
glucose and there is no ATP production. So the KATP channel is 
not closed. When E.littorale is dosed, the glucose lowering effect 
is due to potentiation of glucose–induced insulin release through 
K+ -ATP channel dependent pathway but did not require Ca2+ 
influx. But the number of islets was not increased although it is 
treated with NEL, due to the glucose lowering effect which is due 
to the KATP channel and not  
because of the increase in the number of islets (Figure 22). In 
contrast, STZ administration resulted in severe injury to the 
kidney causing glomerulopathy, mesangial proliferation, reduced 
bowmans space, tubular dilation cortex, glomerular hemorrhage 
and dilated pelvis in the diabetic rats when compared with 
normal rats. Administration of NEL (20 mg/kg bw) showed 
moderate effect; EL (2000 mg/kg b.w) and Insulin showed mild 
effects on the injuries to the kidney when compared to the 
diabetic control. These results supported by glomerular 
expansion have been reported to be a characteristic of 
experimental diabetic animals and humans with diabetes mellitus 
[33-36]. This is highly improved due to the nanoemulsion 
mechanism. Oil-water emulsions are effectively phagocytosed in 
the liver and stomach which enhances the absorption of the 
phytomolecules [37] and showed very good effect when 
compared with the unnanotised ethanolic extract of E.  
littorale.Sodium alginate polymer used for nanoemulsion which 
reduces the release of polyphenol content in the acidic pH (1.2) 
of stomach and a little rapidly in the alkaline pH (7.2) of intestine 
and there is an maximum absorption in the intestine. Aqueous 
extract of E. littorale blume (1g/kg b. wt.) and swertiamarin 
(50mg/kg body wt..), p.o daily for 3 weeks in the type 1 diabetics 
nephropathy induced with streptozotocin (45 mg/kg) in Sprague-
Dawley rats, showed a decrease in serum urea, creatinine and 
lipid profile and also showed an improvement in the 
histopathology of the glomerular function [38]. The 1.5 g dry 
plant equivalent extract of E. littorale /100 g body wt. dosed for 
20 days showed significant decrease in glycosylated 
haemoglobin, liver glucose-6-phosphatase activity and significant 
increase in serum insulin levels of the diabetic rats and toxicity 
was not observed and concluded that it is a potent antidiabetic 
agent without any toxic effect at this particular dose [12]. The 
aqueous extract of E. littorale (2 g/kg p.o.) dosed daily for 6 
weeks in neonatal non-insulin dependent diabetes mellitus 
(NIDDM) rats induce with a single dose injection of STZ (70 
mg/kg; i.p.) was given to the 5-day-old pups. The oral glucose 
tolerance test (OGTT) showed decrease in AUC glucose and 
AUC insulin values, Insulin sensitivity (KITT) index, elevated 
cholesterol, triglyceride and creatinine in NIDDM treated group 
[9]. Methanolic extract of whole plant of E. littorale blume has 
been studied to assess its protective effects in alloxan induced 
diabetic neuropathy in male Charles foster rats. The protective 
effect of Enicostemma littorale blume against neuropathy was 
accredited to controlling hyperglycemia and reducing oxidative 
stress [39]. The chief problem in using plant extracts for 
treatment is the high dose that has to be administered in order to 
deliver the desired therapeutic potential. This issue can be 
potentially resolved using the nanoemulsification method. The 
results of the present study are evidence for this. In addition to 
using a low dose, the nanotized extract lowered the blood 
glucose levels in a short span of 10 days, which encourages the 
use of nanotized preparations for therapy. 
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 Figure:1 
 
 
 
  
Variation in proportion for (A) Total phenol content and (B) loading efficiency for E. littoral. Based 
on the total phenol content (GEA/mg of extract) the loading efficiency was calculated and the 
maximum was observed at 2:18 (mg/ml) for E. littorale extract:olive oil, which is statistically 
different from other proportions *-(p<0.05, ANOVA)  
A 
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Figure 2. (A) Photon correlation spectroscopy of nanoemulsified E. littorale (B, & C) Scanning electron 
microphotograph of nanoemulsified ethanolic plant extracts of E. littorale 
 
  
Figure3.  FT-IR profile for identification of functional groups. (a) Calcium alginate beads (b) crude plant 
extract of E. littorale and (c) nanoemulsified plant extract with sodium alginate crosslinked with 
calcium chloride.  
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Figure 4. Effect of temperature at (4ºC) and (28ºC) for (A & C) Total phenol content and (B & D) loading efficiency of E. littorale. *-(p<0.05, 
ANOVA) . 
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Figure 5. In vitro release at acidic pH (1.2) and alkaline pH (7.2) (A & C) Total phenol content and (B & D) loading 
efficiency of E. littorale *-(p<0.05, ANOVA.  
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Figure 6. Effect of nanoemulsified ethanolic extract of E.littorale and E.littorale treatment on (A) Serum glucose in STZ (B) Triglycerides (C) 
Aspartate transferase (AST) (D) Creatinine (E) Alkaline phosphatase (ALP) (F) Alkaline transferase (ALT) induced type 1 diabetic rats 
during different days of blood collection. Each bar represents mean ± S.E.M. number of animals in each group n=6. G1- Non diabetic 
control, G2-STZ induced diabetic control, G3- ethanolic plant extract (2000 mg/kg b.w), G4 – unnanotised plant extract (20mg/kg b.w), G5 – 
nanotised plant extract, (20 mg/kg b.w), G6- Insulin (1U/kg), on day 5 blood was collected after STZ induced diabetics, Day 10, 15, 20 and 
25 after treatment with nanoeulsified ethanolic plant extract, G7- treated only with plant extract (2000 mg/kg), G8 - Treated only with 
nanotised plant extract (20mg/kg). *- (p<0.05, ANOVA) Significantly different from non-diabetic control. 
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Figure 7. Microphotograph of histopathology of Pancreas of control rat showing (A) 4-5 islets in a view, H&E (40X) (B) Shape, size and 
numbers of beta cells were normal. H&E (200X). 
Figure 8. (A & B) Microphotograph showing histopathology of the pancreas of diabetic rats induced with STZ (A) Number of islets were 
very less and small sized (H&E, 40X) (B & C) Vacuolation, fibrosis and degeneration in islets. (H&E, 200X) (C) Microphotograph 
showing histopathology of the pancreas of diabetic rats induced with STZ (B & C) Vacuolation, fibrosis and degeneration in islets. (H&E, 
200X) 
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Figure 9. Microphotograph showing histopathology of the pancreas of diabetic rats induced with STZ +treated with EL (2000 
mg/kg b.w) (A) Showed little protective effect on pancreatic islets in regard to number, shape, vacuolation, fibrosis and 
degeneration when compared with the diabetic control (A) H&E, 40X (B) H&E, 200X 
 
Figure10.  
Microphotograph showing histopathology of the pancreas of diabetic rats induced with STZ 
+treated with EL (20 mg/kg b.w) (A & B) Showed no effect of EL treatment on pancreatic islets 
when compared with diabetic control. (A) H&E, 40X (B) H&E, 200X  
Figure 11. 
Figure 12. 
Microphotograph showing histopathology of the pancreas of diabetic rats induced with STZ 
+treated with NEL (20 mg/kg b.w), Showed little more effect to protect the pancreas, increase in 
number and size of islets, when compared with the STZ induced diabetics + EL of 2000 mg/kg. (A) 
H&E, 40X (B) H&E, 200X Microphotograph showing histopathology of the pancreas of diabetic rats 
induced with STZ +treated with insulin (1 U/kg b.w)), Showed little more effect to protect the 
pancreas, (A) increase in number and size of islets, when compared with diabetic control. (A) H&E, 
40X (B) H&E, 200X 
Deepa V et al. International Journal of Phytomedicine 4 (1) 70-89 [2012] 
 
PAGE | 83 | 
 
 
 
Figure 13.  
Microphotograph showing histopathology of the pancreas treated with EL (2000 mg/kg b.w) and 
with NEL (20 mg/kg b.w) showed normal histology like control rats, 2-3 islets in a view, normal 
round Shape & size, H&E, 40X.  
 
Figure 14.  
Microphotograph showing normal histology of the control rat of kidney (A) cortex, H&E, 100X (B) 
pelvis area, H&E, 40X  
Figure 15.  
Microphotograph showing normal histology of the control rat of kidney (A) tubules and glomerulus, 
H&E, 200X and (B ) glomerulus H&E, 400X  
Figure 16.  
Microphotograph showing histopathology of the diabetic rats kidney induced with STZ (A) Tubular 
dilatation cortex, glomerular hemorrhage , H&E, 200X (B) Glomerulopathy, mesangial proliferation, 
Reduced bowman’s space, H&E, 200X  
Figure 17.  
Microphotograph showing histopathology of the diabetic rats induced with STZ. Dilated 
pelvis H&E, 40X.  
kidney  
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Figure 18.  
Microphotograph showing histopathology of kidney of the diabetic rats induced with STZ and 
treated with EL (2000 mg/kg b.w) showed little  
 
 
protective/ameliorating effect on histological architecture as compared with the diabetic control H&E, 100X  
 
 
Figure 19.  Microphotograph showing histopathology of the kidney of diabetic rats induced with STZ +treated with EL (20 mg/kg 
b.w) showed no protective effect when compared with diabetic control (A) Glomerulopathy, mesangial proliferation, 
Reduced bowman’s space H&E, 200X (B) Tubular dilatation, cortex, H&E, 200X.  
Figure 20.  Microphotograph showing histopathology of the kidney of diabetic rats induced with STZ +treated with NEL (20 
mg/kg b.w), Showed pronounced effect to protect the kidney (A) Glomerulopathy, mesangial proliferation, Reduced 
bowman’s space H&E, 200X (B) Tubular dilatation, cortex, H&E, 200X  
Figure 21.  Microphotograph showing histopathology of the kidney of diabetic rats induced with STZ +treated with insulin (1 U/kg 
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b.w)).Showed pronounced effect to protect the kidney (A) Glomerulopathy, mesangial proliferation, Reduced bowman’s 
space H&E, 200X (B)  
Figure 22.Mechanism of insulin secretion from beta cells and the effect of STZ(streptozoticin) for the insulin secretion and treatment with 
Enicostemma littorale (EL) and nanoemulsified Enicostemma littorale (NEL). 
Table -1A:  Signs of toxicity for STZ induced diabetics treated with NEL and  EL from 0 to 12  days.  
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Table-1 B: Signs of toxicity for STZ induced diabetics treated with NEL and EL in male Wistar rats from 13 to 25 days 
 
1.Alopecia  6. Coma  11.Erythema  16.Nasal irritation  21.Prostration  
2.Catalepsy  7.Death  12.Eschar formation  17.Nostrial discharge  22.Respiratory distress  
3.Chromodacryorrhea  8. Diarrhea  13.Exophthalmos  18.Paralysis  23.Rigidity  
4.Change of body coat color  9. Dullness  14.Hyperactivity  19.Piloerection  24.Salivation  
5.Convulsion  10. Edema  15.Lacrimation  20.Polyuria  25.Tremor  
TABLE – 2: Mean Body Weight of streptozoticin induced diabetics treated with NEL and EL in male wistar rats  
 
Deepa V et al. International Journal of Phytomedicine 4 (1) 70-89 [2012] 
 
PAGE | 87 | 
 
 
 
Table-3: Urinalysis parameters in STZ induced diabetics treated with NEL and EL in male Wistar rats.  
 
STZ – Streptozoticin, EL-E. littorale, NEL-Nanoemulsified E. littorale 
Py - Pale Yellow, Cl- Clear, Cry-Crystals, Hc- Hyaline Casts, RBC- Red Blood Cells, Dy - Deep Yellow, T –Turbid, C – 
Casts,Gc - Granular Casts, WBC - White Blood Cells, Y – Yellow,  Ap-Appear,  S – Small, Sp- Spermatozoa, TP - Triple 
Phosphate, N – Negative, Tr – Trace, L – Large, M- Moderate, E - Epithelial Cells
Conclusion 
Nanocapsules containing ethanolic extract of Enicostemma 
litrorale were prepared by emulsion coacervation method using 
sodium alginate. An oral dose of E. littorale nanocapsules that is 
100 times less than the ethanolic extract of the herb could exhibit 
similar anti-diabetic effects. Thus, NEL rapidly ameliorates 
increased glucose levels in diabetic conditions due to sustained 
release than its unnanotized counterpart. In addition, the 
preparation did not invoke any toxic response in the 
experimental animals, thereby proving its safety. Hence, 
nanoemulsification can be efficiently utilized for ethanolic 
extracts with high therapeutic potential such as E.littorale. The 
efficiency and stability of the extracts are enhanced by this 
method. Furthermore, this method can be efficiently utilized for 
other plant extracts which are poorly soluble in water. 
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